← Leaderboards
Herbert Tod Cohen
Boston Medical Center
$5,497,344
Attributed
$5,497,344
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $640.8K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$5,497,344 · 2
By mechanism
R01$5,497,344 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Tumor Suppressor Proteins”
- Scott W Lowe · Sloan-Kettering Inst Can Research$30,621,807
- Carol Prives · Icahn School Of Medicine At Mount Sinai$25,974,663
- Pier Paolo Pandolfi · Sloan-Kettering Institute For Cancer Res$25,707,040
- Xinbin Chen · Medical College Of Georgia (Mcg)$23,449,975
- Carlo M Croce · Thomas Jefferson University$21,878,300
- Wei Gu · Columbia University Health Sciences$21,628,257
Research focus
Tumor Suppressor ProteinsMemberLaboratoriesPlantsProteinsProtein FamilyKidneyPathway InteractionsProtein Protein InteractionBinding (Molecular Function)Protein DegradationPropertyCystic KidneyGeneticMutationGrowthAccountingHomeodomainMutateCancer RiskCancer EtiologyMedicalMalignant NeoplasmsMediating
Grant awards (20)
The pVHL/Jade-1/beta-catenin axis in renal cancer$310,590
R01 · FY2014 · CA · contact PI
The pVHL/Jade-1/beta-catenin axis in renal cancer$66,893
R01 · FY2014 · CA · contact PI
The pVHL/Jade-1/beta-catenin axis in renal cancer$300,984
R01 · FY2013 · CA · contact PI
The pVHL/Jade-1/beta-catenin axis in renal cancer$64,824
R01 · FY2013 · CA · contact PI
The pVHL/Jade-1/beta-catenin axis in renal cancer$320,196
R01 · FY2012 · CA · contact PI
The pVHL/Jade-1/beta-catenin axis in renal cancer$22,311
R01 · FY2012 · CA · contact PI
The pVHL/Jade-1/beta-catenin axis in renal cancer$320,196
R01 · FY2011 · CA · contact PI
The pVHL/Jade-1/beta-catenin axis in renal cancer$330,099
R01 · FY2010 · CA · contact PI
Jade-1 in cystic renal disease$296,216
R01 · FY2008 · DK · contact PI
VHL, Jade-1 and protein stability in renal cancer$305,314
R01 · FY2007 · CA · contact PI
Jade-1 in cystic renal disease$302,261
R01 · FY2007 · DK · contact PI
VHL, Jade-1 and protein stability in renal cancer$314,433
R01 · FY2006 · CA · contact PI
Jade-1 in cystic renal disease$311,289
R01 · FY2006 · DK · contact PI
VHL, Jade-1 and protein stability in renal cancer$322,000
R01 · FY2005 · CA
Jade-1 in cystic renal disease$318,780
R01 · FY2005 · DK
VHL, Jade-1 and protein stability in renal cancer$322,000
R01 · FY2004 · CA
Jade-1 in cystic renal disease$318,780
R01 · FY2004 · DK
VHL, Jade-1 and protein stability in renal cancer$322,000
R01 · FY2003 · CA
VEGF TRANSCRIPTIONAL REGULATION BY TUMOR SUPPRESSOR VHL$335,513
R01 · FY2001 · CA
VEGF TRANSCRIPTIONAL REGULATION BY TUMOR SUPPRESSOR VHL$292,665
R01 · FY2000 · CA